Sign in
4

Changes in Ownership

Emmaus Life Sciences, Inc. Filed Acc 0001209191-20-048501

Chairman and CEO bought 750 shares at an average $1.60 ($1,198)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Niihara Yutaka Chairman and CEO 2020-08-25 Purchase +500 $1.60 $800 10,678,746 D
Niihara Yutaka Chairman and CEO 2020-08-26 Purchase +250 $1.59 $398 10,678,996 D
Open-market purchases · 750 sh · avg $1.60 · $1,198
Loading xslF345X03/doc4.xml…